[otw_shortcode_button href=”https://isobm2016congress.com/wp-content/uploads/2016/01/43rd-ISOBM-Congress-Program-Abstracts-191-236-1.pdf” size=”large” icon_type=”general foundicon-down-arrow” icon_position=”left” shape=”radius” color_class=”otw-orange”]Download ISOBM Schedule [/otw_shortcode_button]
Registration and Exhibition Hours for ISOBM 2017
Location: Rendezvous Area
Registration Hours:
Wednesday, August 31: 3:00 PM – 9:00 PM
Thursday, September 1: 8:00 AM – 4:00 PM
Friday, September 2: 8:00 AM – 5:00 PM
Saturday, September 3: 8:00 AM – 4:00 PM
Sunday, September 4: 8:00 AM – 5:00 PM
Monday, September 5: 8:00 AM – 5:00 PM
Tuesday, September 6: 8:00 AM – 11:00 AM
Exhibition Hours:
[Vendor Setup: Wednesday, August 31, 9:00AM – 3:00PM]
Wednesday, August 31: 3:00 PM – 9:00 PM
Thursday, September 1: 8:00 AM – 4:00 PM
Friday, September 2: 8:00 AM – 5:00 PM
Saturday, September 3: 8:00 AM – 4:00 PM
Sunday, September 4: 8:00 AM – 5:00 PM
Monday, September 5: 8:00 AM – 5:00 PM
Tuesday, September 6: 9:00 AM – 1:30 PM
DAY ONE (Thursday, September 1st)
Grant Park Room
8:00 AM – 11:45 AM | ISOBM Board Meeting |
11:45 AM – 12:45 PM | Student Orientation |
Gold Room
Opening Ceremony
1:00 PM – 1:08 PM | Welcome Video | |
1:08 PM – 1:13 PM | Welcome & Opening Remarks | Dr. James Radosevich, Congress President |
1:13 PM – 1:16 PM | Star Spangled Banner | Megan McLaughlin |
1:16 PM – 1:20 PM | Illinois State Anthem | Megan McLaughlin |
1:20 PM – 1:25 PM | Welcome Remarks | Dr. Robert Barish, Vice Chancellor for Health Affairs, University of Illinois at Chicago |
1:25 PM – 1:30 PM | Introduction of Elliott Gunmaker & Ho Chunk Drummers | Dr. James Radosevich, Congress President |
1:30 PM – 1:50 PM | Ho Chunk Drummers Performance |
Rendevzous Area
1:50 PM – 2:00 PM | Coffee Break |
Gold Room
Keynote Presentations
Introductions: Dr. B. Aydogan (USA)
2:00 PM – 3:00 PM | Targeting DNA Repair in Oncology | Dr. P. Connell |
3:00 PM – 4:00 PM | Title TBA | Dr. C. Croce |
4:00 PM – 4:05 PM | Closing Remarks | Dr. James Radosevich, Congress President |
Signature Room at the John Hancock Building
Opening Reception
5:45 PM | VIPs meet at front entrance of hotel to board bus to Hancock Building |
6:15 PM | VIP bus arrives at Hancock Building |
6:25 PM | Attendees meet at front entrance of hotel to board buses to Hancock Building |
6:45 PM | First attendees arrive at Hancock Building — Receiving line at the Hancock Building on the 95th Floor Set Up (VIPs/ Board members) |
7:00 PM – 9:30 PM | Reception at the Hancock Building |
9:30 PM – 10:00 PM | Buses back to the Congress Hotel |
DAY TWO (Friday, September 2nd)
Florentine Room
Scientific Session: Early Cancer Detection
Chairpersons: Dr. I. Cree (UK), Dr. C. Chapman (UK), Dr. A. Murray (UK)
8:00AM – 8:20AM | Plasma cfDNA for Early Cancer Detection | Dr. I. Cree |
8:20AM – 8:40AM | Autoantibodies in Lung Cancer Detection | Dr. C. Chapman |
8:40AM – 9:00AM | Improvement in Performance of the EarlyCDT-Lung Test for Detection of Lung Cancer by Addition of Antigenic Biomarkers | Dr. A. Murray |
9:00AM – 9:20AM | Lung Cancer Screening Initiative with Cuba | Dr. K. Tossas-Milligan |
9:20AM – 9:40AM | A Novel Serological Marker for Pancreatic Cancer | Dr. K. Taniuchi |
9:40AM – 10:00AM | Abbott ARCHITECT® AFP and PIVKA II for Early Detection of Hepatocellular Carcinoma | Dr. P. Hemken |
Gold Room
Scientific Session: Breast Cancer Biomarkers & Oncogenes
Chairpersons: Dr. V. Barak (Israel), Dr. H. Batool (Dubai), Dr. R. Molina (Spain)
8:00 AM – 8:30 AM | Serum HER-2 as a Sensitive Tumor Marker in Breast Cancer Patients | Dr. V. Barak |
8:30 AM – 9:00 AM | Immunotherapy in Endocrine Dependent Metastatic Breast Cancer | Dr. A. Nicolini |
9:00 AM – 9:20 AM | Mutant p53 as a New Therapeutic Target for Breast Cancer Treatment | Dr. M.J. Duffy |
9:20 AM – 9:40 AM | Circulating Levels of HER-2/neu Oncoprotein in Breast Cancer: Clinical Utility as Tumor Marker and in Therapy Monitoring | Dr. R. Molina |
9:40 AM – 10:00 AM | Round Table Discussion |
Rendevzous Area
10:00 AM – 10:30 AM | Coffee Break |
Florentine Room
Scientific Session: Tumor Hypoxia for Prediction of Response & Cancer Prognosis
Chairpersons: Dr. H. Halpern (USA), Dr. B. Aydogan (USA), Dr. B. Clifford (USA)
10:30AM – 11:00AM | Tumor Hypoxia for Prediction of Response and Cancer Prognosis | Dr. H. Halpern |
11:00AM – 11:20AM | Towards Oxygen-Guided Radiation Therapy Validation in Mice Model | Dr. B. Epel |
11:20AM – 11:40AM | Using Electron Paramagnetic Resonance (EPR) to Identify Hypoxic Microenvironments in Tumors Expressing Hypoxia-Induced Proteins | Dr. R. Miller |
11:40AM – 12:00PM | Imaging Transient Hypoxia in Tumors Using Fast Low-Rank Tensor Based EPR Imaging with Physical Priors | Dr. B. Clifford |
Gold Room
Scientific Session: Imaging as Biomarkers in Oncology
Chairpersons: Dr. B. Aydogan (USA)
10:30 AM – 10:50 AM | Imaging as Cancer Biomarker for Diagnosis, Targeting, and Treatment Response | Dr. B. Aydogan |
10:50 AM – 11:25 AM | X-ray Absorption, Fluorescence, and Luminescence as Potential Cancer Biomarkers | Dr. P. LaRiviere |
11:25 AM – 12:00 PM | Advanced Diffusion MRI Techniques for Cancer Diagnosis and Treatment Monitoring | Dr. J. Zhou |
Plaza/Belmont/Francis I
12:00 PM – 12:45 PM | Lunch |
Gold Room
Keynote Presentations
Introductions: Dr. V. Barak (Israel), Dr. R. Molina (Spain)
12:45 PM – 1:45 PM | Liver Cancer and Liver Cancer Biomarkers | Dr. J. Marrero |
1:45 PM – 2:30 PM | Title TBA | Dr. R. Bikkavilli |
2:30 PM – 3:15 PM | Oral Microbiome as Biomarkers for Head and Neck Cancers | Dr. J. Schwartz |
Rendevzous Area
3:15 PM – 3:30 PM | Coffee Break |
Florentine Room
Scientific Session: Circulating Cancer Cells & Biomarkers
Chairpersons: Dr. S. Holdenrieder (Germany), Dr. J. Borgia (USA), Dr. L. Feldman (USA)
3:30 PM – 4:00 PM | Serum biomarkers associated with disease progression in non-small cell lung cancer | Dr. J. Borgia |
4:00 PM – 4:20 PM | Title TBA | Dr. L. Feldman |
4:20 PM – 4:40 PM | The Effect of p85-sHER3 on Cancer Cell Growth and Migration: Requirement for Tenascin-C | Dr. S.K. Rajpurohit |
Gold Room
Scientific Session: Targeted Cancer Therapies & Stem cell
Chairpersons: Dr. J. Radosevich (USA), Dr. J. Chowdhury (USA), Dr. J. LaBelle (USA)
3:30 PM – 3:45 PM | Nitric Oxide on Cancer Stem Cells | Dr. J. Radosevich |
3:45 PM – 4:00 PM | Massive Oval (Stem) Cell Proliferation in Livers of Genetically Altered Mice after Aflatoxin Exposure | Dr. S. Sell |
4:00 PM – 4:15 PM | Reactivation of Cancer Cell Death Using Novel Peptide Based Therapeutics | Dr. J. LaBelle |
4:15 PM – 4:30 PM | IGF1R Blockades for Gastrointestinal Cancer Cells with Mutated Kras Gene | Dr. Y. Adachi |
4:30 PM – 4:45 PM | Selected Growth Factors and Different Gastric Neoplasms in Humans | Dr. B. Wojciech |
4:45 PM – 5:00 PM | A Rat Model for Nanoparticle Directed Treatment and Prevention of Liver Cancer | Dr. S. Sell |
5:00 PM – 5:15 PM | Carboxypeptidase M (Cpm) Contributes Tumor Growth and Metastasis Related in Epithelial Mesenchymal Transition in Human Esophageal Carcinoma | Dr. K. Kato |
Poster Presentations at University of Illinois at Chicago (UIC), College of Dentistry
6:00PM | Poster presenters/VIPs meet at front entrance of hotel to board bus to UIC |
6:15PM | Attendees meet at front entrance of hotel to board bus to UIC |
6:30 PM – 9:30 PM | Poster Session & Chicago Deep Dish Style Pizza |
DAY THREE (Saturday, September 3rd)
Florentine Room
Scientific Session: Upper Respiratory Biology & Biomarkers
Chairpersons: Dr. L. Feldman (USA), Dr. P. Bonomi (USA), Dr. Jeff Borgia (USA)
8:00 AM – 8:45 AM | Molecular Markers in Non-Small Cell Lung Cancer | Dr. P. Bonomi |
8:45 AM – 9:30 AM | Validation of an Algorithm Using Tumor Markers, Clinical Data, and Imagine Techniques to Help in the Diagnosis and Histological Diagnosis of Lung Cancer | Dr. R. Molina |
9:30 AM – 9:45 AM | Serial Tumor Marker Determination in Therapy Monitoring of Small Cell Lung Cancer Patients | Dr. S. Holdenreider |
9:45 AM – 10:00 AM | Transcriptomic and Methylome Approaches to Identify Genetic Alterations in Esophageal Cancer of India | Dr. I. Chattopadhyay |
Gold Room
Scientific Session: Current Issues in Gastrointestinal & Gynecological Cancer
Chairpersons: Dr. M.J. Duffy (Ireland), Dr. L. Feldman (USA), Dr. K. Batool (USA)
8:00 AM – 8:15 AM | Differential Levels of Hypoxia-Induced Factor-1a and 2a in Hepatocellular Carcinomas | Dr. G. Chen |
8:15 AM – 8:30 AM | The Combination of uPAR(I) and Type IV Collagen Outperforms CEA as a Prognostic Biomarker in Primary Colorectal Cancer | Dr. I. Christensen |
8:30 AM – 8:45 AM | Colorectal Cancer Associated Biomarkers: The Effect of Bowel Preparation | Dr. N. Pedersen |
8:45 AM – 9:00 AM | Increased Serological Protein Biomarker Levels at Diagnostic Bowel Endoscopy Are Associated with Risk of Being Diagnosed with Subsequent Primary Malignancy | Dr. T. Piper |
9:00 AM – 9:15 AM | Glad-PCR Assay of DNA Methylation Markers Associated with Colorectal Cancer | Dr. A. Evdokimov |
9:15 AM – 9:30 AM | Prototype Biomarker Panel Algorithms for Aiding in Early Colorectal Cancer (CRC) Detection | Dr. G. Davis |
9:30 AM – 9:45 AM | A Reflex Algorithm for Identifying Presence of Extra-Colonic Cancers in False-Positive CRC Screened Subjects | Dr. S. Gawel |
9:45 AM – 10:00 AM | Epigenetic Profiling of Circulating Cell Free Nucleosomes: A Novel Approach to Reducing the Impact of Colorectal Cancer | Dr. M. Eccleston |
10:15AM – 10:30AM | Biomarker & Early Detection of Ovarian Cancer | Dr. A. Barua |
Rendevzous Area
10:15 AM – 10:30 AM | Coffee Break |
Florentine Room
Session Title: Targeted Immunotherapies
Chairpersons: Dr. M. Chechlinska (Poland), Dr. J. Labelle (USA)
10:30AM – 10:45AM | Deletion of DNA-Binding Inhibitor Id3 Enhances Anticancer Function of T Cells by Inducing Th9 Cells | Dr. D. Zhang |
10:45AM – 11:00AM | An Anti-PSMA Immunotoxin Induces Apoptosis and Efficiently Eliminates Prostate Cancer Cells in Combination with ABT-737 | Dr. M. Michalska |
Gold Room
Scientific Session: Liquid Biopsies and Serum Assays
Chairpersons: Dr. C. Mandal (India), Dr. Borgia (USA), Dr. Thomas (USA)
10:30 AM – 10:45 AM | Targeting Cellular Cholesterol Might Be a Therapeutic Strategy for Breast Cancer Bone Metastasis | Dr. C. Mandal |
10:45 AM- 11:00 AM | Early Detection of Neoplasia | Dr. M. Wilhelmsen |
Gold Room
Keynote Presentation
Introduction: Dr. C. Maki (USA)
11:00AM – 12:00PM | Evolving Role of Precision Medicine to Guide Decision Making in Oncology | Dr. A. Dudek |
Plaza/Belmont/Francis I
12:00 PM – 12:45 PM | Lunch |
Gold Room
Keynote Presentations
Introductions: R. Molina (Spain), V. Barak (Israel)
12:45 PM – 1:45 PM | Discovery of Cyclic GMP and Nitric Oxide in Cell Signaling and Their Role in Drug Development | Dr. F. Murad |
1:45 PM – 2:30 PM | Vitamin D Receptor and Cancer | Dr. M. Kadakia |
2:30 PM – 3:00 PM | Title TBA | Dr. G. Adami |
Rendevzous Area
3:00 PM – 3:15 PM | Coffee Break |
Florentine Room
Scientific Session: Circulating Tumor Nucleosomes, DNA & Genetics
Chairpersons: Dr. S. Holderieder (Germany), Dr. E. Yoruker (Turkey), Dr. S. Sell (USA)
3:15 PM – 3:30 PM | Circulating Cell Free Nucleosome Levels Are Not Affected by Stage of CRC, Comorbidity or Demographic Variables | Dr. L. Rasmussen |
3:30 PM – 3:45 PM | Targeted Exome Sequencing of Cancer-Related Genes in Human Cancers Using the Semiconductor Sequencer | Dr. Y. Sasaki |
3:45 PM – 4:00 PM | Phenothiazines Modulate Chromatin-Related DNA Repair Signaling in Tumors | Dr. P. Hååg |
4:00 PM – 4:15 PM | Significance Estimation of EGFR and Their Polymorphisms in Non-Small Cell Lung Cancer | Dr. V. Jurisic |
Gold Room
Session Title: Hot Topics in Cancer Research
Chairpersons: Dr. Malaiyanda (USA), Dr. Patel (India), Dr. J. Chowdhury (USA)
3:15 PM – 3:30 PM | Diagnostic Value of Interleukin-31and 33 in Endometrial Cancer | Dr. Xi Zeng |
3:30 PM – 3:45 PM | Biopsy Levels of miR-375, miR-200b and miR-29c Associated with Prognosis of Head and Neck Cancers | Dr. Jaromir Gumulec |
3:45 PM – 4:00 PM | The Role of Human DNA Repair Protein APE1/Ref-1 in Transcriptional Regulation of Genes Involved in Cancer Development | Dr. Milena Bazlekowa |
4:00 PM – 4:15 PM | Anticancer Effects Elicited by Combination of Rubus Extract with Phthalocyanine Photosensitiser on MCF-7 Cells | Dr. G. Blassan |
Odyssey Boat Cruise at Navy Pier
5:00 PM | Meet at front entrance of hotel to board bus to Navy Pier |
7:00 PM | Last boarding of ship |
7:00 PM – 11:00 PM | Lake Michigan Dinner / Dance Cruise |
11:00 PM- 12:00 AM | Buses back to hotel |
DAY FOUR (Sunday, September 4th)
Florentine Room
Session Title: Clinical Applications of Cancer Biomarkers
Chairpersons: Dr. Sanchez-Carbayo (Spain), Dr. R. Molina (Spain), Dr. H. Batool (USA)
8:30 AM – 9:00 AM | HE4 a New Tumor Marker in Ovarian Cancer: Controversies and Clinical Applications | Dr. R. Molina |
9:00 AM – 9:15AM | Soluble Epha2 Has a Potential of Novel Serum Biomarker for Malignant Cancers | Dr. T. Kondo |
9:15 AM – 9:30 AM | Protocol: Detection of False FIT Negative Subjects by Combinations of Blood-Based Biomarkers | Dr. H. Nielsen |
9:30 AM – 9:45 AM | PMF-1 Methylation Is a Prognostic and Predictive Biomarker of Sunitinib Response in Patients with Kidney Cancer | Dr. M. Sánchez-Carbayo |
9:45 AM – 10:00 AM | Diagnostic Performance of Tumor Makers AFP and PIVKA-II in Chinese Hepatocellular Carcinoma Patients | Dr. X. Wang |
Gold Room
Session Title: Tumor Immunology
Chairpersons: Dr. Nicolini (Italy), Dr. Malaiyandi (USA), Dr. Nap (Netherlands)
8:30 AM – 8:45 AM | MicroRNAs as Molecular Markers in Central Nervous System Lymphomas | Dr. M. Chechlinska |
8:45 AM – 9:00 AM | Investigation of Putative Molecular Marker in Human Papillomavirus Associated Cervical Cancer in Indian Population | Dr. M. Bharadwaj |
9:00 AM – 9:15 AM | Evaluation of an Improved Version of the Arocell TK 210 ELISA for Determining TK1 Protein Levels In Serum Samples | Dr. K. Jagarlamudi |
9:15 AM – 9:30 AM | Human Papillomavirus, an Oncogenic SUMO Wrestler | Dr. A. Nag |
9:30 AM – 9:45 AM | Investigation of Snps/Haplotypes as Biomarkers to Tobacco Associated Oral Squamous Cell Carcinoma in Indian Population | Dr. M. Bharadwaj |
9:45 AM – 10:00 AM | The Influence of PSA Autoantibodies in Prostate Cancer | Dr. K. Nakajima |
Rendevzous Area
10:00 AM – 10:30 AM | Coffee Break |
Gold Room
Session Title: Current Topics in Liver & Pancreatic Carcinomas
Chairpersons: Dr. Bassiony (Egypt), Dr. De Vitto (Brazil), Dr. Nag (India)
10:30 AM – 10:45 AM | A Novel Biomarker for Early Diagnosis of Hepatocellular Carcinoma | Dr. N. Koshikawa |
10:45 AM – 11:00 AM | Cytokine Induction by Trabedersen (OT-101) Treatment: Results from a Phase I/II Trial in Pancreatic Cancer Patients | Dr. L. Hwang |
Gold Room
Keynote Presentation
Introduction: Dr. Malaiyandi (USA)
11:00 AM – 12:00 PM | Botanicals as Natural Alternatives to Hormone Replacement Therapy: Role in Breast Cancer Prevention? | Dr. J. Bolton |
Plaza/Belmont/Francis I
12:00 PM – 1:00 PM | Lunch |
Gold Room
Keynote Presentation
Introduction: Dr. K. Dineley (USA)
1:00 PM – 2:00 PM | Wnt5a Modulates Vascularization of Non-Small Cell Lung Cancer | Dr. J. Pongracz |
Rendevzous Area
2:00 PM – 2:30 PM | Coffee Break |
Gold Room
Scientific Session: European Group on Tumour Markers (EGTM)
Chairpersons: Dr. V. Barak (Israel), Dr. R. Molina (Spain), Dr. J. Radosevich (USA)
2:30 PM – 3:00 PM | The Clinical Role of the Immune Biomarker sIL2R in Head and Neck Cancer | Dr. V. Barak |
3:00 PM – 3:30 PM | Biomarkers in Colorectal Cancer: Which Ones are Clinically Useful? | Dr. M.J. Duffy |
3:30 PM – 4:00 PM | Tumor Markers Use for the Differential Diagnostic of Effusions | Dr. R. Molina &
Dr. Trape |
4:00 PM – 4:30 PM | Biomarkers: Best Assays to Assess Response to New Therapies and Provide Prognosis in Melanoma Patients | Dr. V. Barak |
Plaza/Belmont/Francis I
4:30 PM – 6:00 PM | Hor D’oeuvers |
Gold Room
6:00 PM – 8:00 PM | General Assembly (Chaired by Dr. R. Molina) |
DAY FIVE (Monday, September 5th)
Gold Room
Session Title: New Models in Cancer Research
Chairpersons: Dr. K. Batul (Dubai), Dr. C. Chapman (UK), Dr. C. Maki (USA)
9:00 AM – 9:30 AM | Diabetes, metformin and oral precancer progression | Dr. A. Schneider |
9:30 AM – 10:00 AM | Computational simulation models containing NSCLC patient genomic signatures predict drug responder status to anti-PD-1 immunotherapy | Dr. K. Brogden |
10:00 AM – 10:30 AM | Using Pseudomonas Exotoxin T (ExoT) to target apoptotic compensatory proliferation signaling in cancer | Dr. S. Shafikhani |
Rendevzous Area
10:30 AM – 11:00 AM | Coffee Break |
Gold Room
Keynote Presentation
Introduction: Dr. S. Holdenreider (Germany)
11:00AM – 12:00PM | Mechanism-Based Repurposing of Neurodegenerative Disease Drugs for Breast Cancer Treatment | Dr. A. Rana |
Plaza/Belmont/Francis I
12:00 PM – 1:00 PM | Lunch |
Gold Room
Keynote Presentations
Introductions: Dr. R. Molina (Spain), Dr. V. Barak (Israel), Dr. Patel (India), Dr. Borgia (USA)
1:00 PM – 2:00 PM | Developing Precision Medicine for Lung Cancer | Dr. J. Minna |
2:00 PM – 2:30 PM | Title TBA | Dr. R. Winn |
2:30 PM – 3:00 PM | Cold Environment Is a Risk Factor for Cancer | Dr. C. Mandal |
Rendevzous Area
3:00 PM – 3:30 PM | Coffee Break |
Gold Room
Session Title: Mechanisms and Development of New Cancer Agents
Chairpersons: Dr. M.J. Duffy (Ireland), Dr. C. Maki (USA), Dr. J. Chowdhury (USA)
3:30 PM – 3:45 PM | Crosstalk Between p53 and the IGF-IR/AKT mTORCI Pathway Reduces the Effectiveness of IGF-IR | Dr. C. Maki |
3:45 PM – 4:00 PM | TPS an Appropriate Marker for the Follow-up Monitoring of Breast Cancer Patients After Radical Surgery | Dr. R. Kucera |
Rendevzous Area
7:00 PM – 11:00 PM | Gala Dinner |
DAY SIX (Tuesday, September 6th)
Grant Park Room
8:00AM – 9:00AM | Executive ISOBM Board Meeting |
Florentine Room
Scientific Session: Biomarkers in Prostate Cancer
Chairpersons: Dr. R. Szmulewitz (USA)
9:00 AM – 9:30 AM | Hox Protein Regulators as Biomarkers in Prostate Cancer | Dr. D. Vander Griend |
9:30 AM – 10:00 AM | Molecular Biomarkers in Castration Resistant Prostate Cancer: What We Learn From the Blood | Dr. R. Szmulewitz |
Rendevzous Area
10:00 AM – 10:30 AM | Coffee Break |
Florentine Room
Scientific Session: Radiomics & Radiogenomics as Biomarkers in Precision Medicine
Chairpersons: Dr. B. Aydogan (USA), Dr. H. Li (USA)
10:30AM – 11:00AM | Radiomics of Breast Cancer and Associated Challenges with Big Data | Dr. K. Drukker |
11:00AM – 11:30AM | Radiomics in Breast Cancer Risk Assessment | Dr. H. Li |
11:30AM – 11:45AM | Deep Learning in the Radiomics of Breast Cancer Imaging | Dr. B. Huynh |
Florentine Room
12:00 PM – 12:30 PM | Closing Ceremony |
Plaza/Belmont/Francis I
12:30 PM – 1:30 PM | Hor D’oeuvers |
Grant Park Room
1:30 PM | Executive ISOBM Board Meeting |
Floor Plan
[pdf-embedder url=”https://isobm2016congress.com/wp-content/uploads/2016/01/Congress-Plaza-floorplan.pdf”]
[pdf-embedder url=”https://isobm2016congress.com/wp-content/uploads/2016/01/43rd-ISOBM-Congress-Program-Abstracts-191-236-1.pdf”]